Cargando…
A Click Chemistry Approach to Targeted DNA Crosslinking with cis‐Platinum(II)‐Modified Triplex‐Forming Oligonucleotides
Limitations of clinical platinum(II) therapeutics include systemic toxicity and inherent resistance. Modern approaches, therefore, seek new ways to deliver active platinum(II) to discrete nucleic acid targets. In the field of antigene therapy, triplex‐forming oligonucleotides (TFOs) have attracted i...
Autores principales: | Hennessy, Joseph, McGorman, Bríonna, Molphy, Zara, Farrell, Nicholas P., Singleton, Daniel, Brown, Tom, Kellett, Andrew |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9299770/ https://www.ncbi.nlm.nih.gov/pubmed/34652881 http://dx.doi.org/10.1002/anie.202110455 |
Ejemplares similares
-
Enzymatic Synthesis of Chemical Nuclease Triplex-Forming Oligonucleotides with Gene-Silencing Applications
por: McGorman, Bríonna, et al.
Publicado: (2022) -
Secondary binding sites for heavily modified triplex forming oligonucleotides
por: Cardew, Antonia S., et al.
Publicado: (2012) -
Structural Determinants of Photoreactivity of Triplex Forming Oligonucleotides Conjugated to Psoralens
por: Krishnan, Rajagopal, et al.
Publicado: (2010) -
Recognition of RNA duplexes by chemically modified triplex-forming oligonucleotides
por: Zhou, Yuan, et al.
Publicado: (2013) -
Triplex-forming oligonucleotides: a third strand for DNA nanotechnology
por: Chandrasekaran, Arun Richard, et al.
Publicado: (2018)